11 – 20 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Aβ accumulation causes MVB enlargement and is modelled by dominant negative VPS4A
- Contribution to journal › Article
- 2016
-
Mark
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
- Contribution to journal › Article
-
Mark
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
- Contribution to journal › Article
-
Mark
A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein
- Contribution to journal › Article
-
Mark
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF
- Contribution to journal › Article
- 2015
-
Mark
Ceruloplasmin functional changes in Parkinson's disease-cerebrospinal fluid.
- Contribution to journal › Article
- 2014
-
Mark
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
- Contribution to journal › Article
- 2013
-
Mark
Fluid biomarkers in Alzheimer's disease - current concepts
- Contribution to journal › Scientific review
- 2010
-
Mark
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease
- Contribution to journal › Article
-
Mark
BACE1 gene variants do not influence BACE1 activity, levels of APP or A beta isoforms in CSF in Alzheimer's disease
- Contribution to journal › Article
